Article Details
Retrieved on: 2025-01-10 20:55:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Phase 1 clinical trial for ARCT-2304, a self-amplifying mRNA vaccine, seeks to address pandemic influenza risk as H5N1 cases increase.
Article found on: www.contagionlive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here